Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 1036 AL 1050

Optimizing Treatment of Parkinson's Disease

Nyholm D, Bergquist F.

J Pers Med. 2022 Feb 9;12(2):245. doi: 10.3390/jpm12020245.

Personalized Assessment of Insomnia and Sleep Quality in Patients with Parkinson's Disease

Diaconu Ş, Falup-Pecurariu C.

J Pers Med. 2022 Feb 21;12(2):322. doi: 10.3390/jpm12020322.

Small Molecules as Modulators of Voltage-Gated Calcium Channels in Neurological Disorders: State of the Art and Perspectives

Lanzetti S, Di Biase V.

Molecules. 2022 Feb 15;27(4):1312. doi: 10.3390/molecules27041312.

Phlegmacaritones A and B, a Pair of Serratane-Related Triterpenoid Epimers with an Unprecedented Carbon Skeleton from Phlegmariurus carinatus

Wang C, Yang X, Mellick GD, Feng Y.

J Nat Prod. 2022 Apr 22;85(4):899-909. doi: 10.1021/acs.jnatprod.1c01021. Epub 2022 Feb 25.

What are the main considerations when prescribing pharmacotherapy for Parkinson's disease?

Müller T.

Expert Opin Pharmacother. 2022 May;23(7):745-750. doi: 10.1080/14656566.2022.2045275. Epub 2022 Feb 25.

Angiopep-2-Modified Nanoparticles for Brain-Directed Delivery of Therapeutics: A Review

Habib S, Singh M.

Polymers (Basel). 2022 Feb 12;14(4):712. doi: 10.3390/polym14040712.

Ferritinophagy and α-Synuclein: Pharmacological Targeting of Autophagy to Restore Iron Regulation in Parkinson's Disease

Boag MK, Roberts A, Uversky VN, Ma L, Richardson DR, Pountney DL.

Int J Mol Sci. 2022 Feb 21;23(4):2378. doi: 10.3390/ijms23042378.

Polygenic burden of Parkinson's disease risk stratifies the prognosis of isolated rapid-eye-movement disorder: A preliminary observational study

Tsukita K, Sakamaki-Tsukita H, Tachibana N, Takahashi R.

Parkinsonism Relat Disord. 2022 Mar;96:52-56. doi: 10.1016/j.parkreldis.2022.02.005. Epub 2022 Feb 19.

COMT Inhibitors in the Management of Parkinson's Disease

Fabbri M, Ferreira JJ, Rascol O.

CNS Drugs. 2022 Mar;36(3):261-282. doi: 10.1007/s40263-021-00888-9. Epub 2022 Feb 25.

A Randomized, Double-Blind, Controlled Phase II Study of Foliglurax in Parkinson's Disease

Rascol O, Medori R, Baayen C, Such P, Meulien D; AMBLED Study Group.

Mov Disord. 2022 May;37(5):1088-1093. doi: 10.1002/mds.28970. Epub 2022 Feb 26.

Fighting Parkinson's disease: The return of the mitochondria

Zambrano K, Barba D, Castillo K, Noboa L, Argueta-Zamora D, Robayo P, Arizaga E, Caicedo A, Gavilanes AWD.

Mitochondrion. 2022 May;64:34-44. doi: 10.1016/j.mito.2022.02.003. Epub 2022 Feb 24.

What about the role of the cerebellum in music-associated functional recovery? A secondary EEG analysis of a randomized clinical trial in patients with Parkinson disease

Naro A, Pignolo L, Bruschetta D, Calabrò RS.

Parkinsonism Relat Disord. 2022 Mar;96:57-64. doi: 10.1016/j.parkreldis.2022.02.012. Epub 2022 Feb 23.

Improving functional disability in patients with tremor: A clinical perspective of the efficacies, considerations, and challenges of assistive technology

Bhidayasiri R, Maytharakcheep S, Phumphid S, Maetzler W.

J Neurol Sci. 2022 Apr 15;435:120197. doi: 10.1016/j.jns.2022.120197. Epub 2022 Feb 19.

Non-invasive electrical stimulation of peripheral nerves for the management of tremor

Pascual-Valdunciel A, Rajagopal A, Pons JL, Delp S.

J Neurol Sci. 2022 Apr 15;435:120195. doi: 10.1016/j.jns.2022.120195. Epub 2022 Feb 19.

Mitochondrial Sirtuins in Parkinson's Disease

He L, Wang J, Yang Y, Li J, Tu H.

Neurochem Res. 2022 Jun;47(6):1491-1502. doi: 10.1007/s11064-022-03560-w. Epub 2022 Feb 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias